Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control

J Reid; J M Lawrence; G J Taylor; C A Stirling; J P D Reckless

Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control

J Reid, J M Lawrence, G J Taylor, C A Stirling, J P D Reckless

Department for Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	330-330
Number of pages	1
Journal	Atherosclerosis Supplements
Volume	7
Issue number	3
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{b7a01d48cc8a44518d502b81218e80da,

title = "Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control",

author = "J Reid and Lawrence, {J M} and Taylor, {G J} and Stirling, {C A} and Reckless, {J P D}",

note = "ID number: ISI:000239093902096",

year = "2006",

language = "English",

volume = "7",

pages = "330--330",

journal = "Atherosclerosis Supplements",

issn = "1567-5688",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control

AU - Reid, J

AU - Lawrence, J M

AU - Taylor, G J

AU - Stirling, C A

AU - Reckless, J P D

N1 - ID number: ISI:000239093902096

PY - 2006

Y1 - 2006

M3 - Article

VL - 7

SP - 330

EP - 330

JO - Atherosclerosis Supplements

JF - Atherosclerosis Supplements

SN - 1567-5688

IS - 3

ER -